Contemporary use of P2Y(12) inhibitors in patients with ST-segment elevation myocardial infarction referred to primary percutaneous coronary interventions in Poland: Data from ORPKI national registry

According to guidelines, it is recommended to give P2Y(12) inhibitors (preferably ticagrelor or prasugrel) at the time of first medical contact in patients with STEMI. However, in real life antiplatelet treatment strategies are different among countries. We analyzed data on antiplatelet treatment in...

Descripción completa

Detalles Bibliográficos
Autores principales: Rakowski, Tomasz, Siudak, Zbigniew, Dziewierz, Artur, Plens, Krzysztof, Kleczyński, Paweł, Dudek, Dariusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756271/
https://www.ncbi.nlm.nih.gov/pubmed/29075924
http://dx.doi.org/10.1007/s11239-017-1579-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756271/
https://www.ncbi.nlm.nih.gov/pubmed/29075924
http://dx.doi.org/10.1007/s11239-017-1579-9

Ejemplares similares